Quarterly Result18 Mar 2026, 04:58 pm
Dharti Proteins Ltd. Approves Q3 and Nine Months Financial Results for 2025, Announces Resolution Plan Implementation
AI Summary
Dharti Proteins Ltd. held a Board of Directors meeting on March 18, 2026, where they approved the un-audited standalone financial results for the quarter and nine months ended December 31, 2025. The company will disclose its financial results on or before March 31, 2026, as per NCLT orders. The meeting was conducted through video conferencing and concluded with key decisions, including the implementation of the approved Resolution Plan, which will reduce existing public shareholding and allot equity shares to Financial Creditors and the Successful Resolution Applicant's group of promoters.
Key Highlights
- Dharti Proteins Ltd. approved the un-audited standalone financial results for Q3 and nine months ended December 31, 2025.
- The company is set to disclose its financial results on or before March 31, 2026, in accordance with NCLT orders.
- The Board of Directors meeting was conducted through video conferencing and concluded with key decisions related to the implementation of the approved Resolution Plan.
- The approved Resolution Plan will reduce existing public shareholding and allot equity shares to Financial Creditors and the Successful Resolution Applicant's group of promoters.
- The company has been inoperative for a few years, with no trading or manufacturing activities during the period under review, leading to concerns about its ability to continue as a going concern.